Molecular Diagnostics
News on lab-developed tests and emerging diagnostic technologies.
Doctors and patient advocates supporting pretreatment testing at times challenged FDA and other experts who aren't swayed by available evidence.
Guardant Health Reveal Assay Gets Additional Medicare Coverage for CRC Surveillance Testing
The test was previously covered for use in colorectal cancer patients in the early postsurgical setting only.
In Brief This Week: Mayo Clinic Laboratories, Spear Bio, PreludeDx, ERS Genomics, Aspen Neuroscience
News items for the week of Jan. 13, 2025.
Foundation Medicine Assay Nabs FDA Approval as CDx for Ojemda in Pediatric Patients
The FoundationOne test can be used to identify patients with relapsed or refractory BRAF-altered pediatric low-grade glioma who may be eligible for therapeutic options.
Mass General Brigham Becomes Latest US Health System to Adopt Pretreatment DPYD Testing
The change in policy at the health system follows the death of a DPD deficient patient and comes during a period of intense competition among Boston hospitals.
Jan 6, 2025
Dec 20, 2024
Dec 19, 2024
Dec 13, 2024